arrow
L

Leanna Wise

University of Southern California
H指数:15
被引数:1,296

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of Risk Factors on COVID-19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID-19 Global Rheumatology Alliance Registry

风险因素对未接种疫苗的风湿性疾病患者新型冠状病毒肺炎结局的影响: 使用新型冠状病毒肺炎全球风湿病联盟注册表对大流行时期的比较分析

2023-11-075
OA
Association Between Race/Ethnicity and COVID-19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID-19 Global Rheumatology Alliance

种族/民族与美国系统性红斑狼疮患者新型冠状病毒肺炎结局之间的关系: 来自新型冠状病毒肺炎全球风湿病学联盟的数据

2022-12-0212
OA
Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study

环境和社会因素与风湿性疾病患者COVID-19-related死亡相关: 一项观察性研究

2022-09-0111
OAAI
SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta-analysis

风湿性疾病的SARS-CoV-2感染和新型冠状病毒肺炎结局: 系统文献回顾和荟萃分析

2022-03-28127
OAAI
Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

新型冠状病毒肺炎全球风湿病联盟医师注册中心原发性系统性血管炎或风湿性多肌痛患者的新型冠状病毒肺炎结果: 一项回顾性队列研究

2021-12-0144
OAAI
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19

肿瘤坏死因子抑制剂与免疫介导性炎性疾病和新型冠状病毒肺炎患者住院或死亡风险的相关性

2021-10-1891
OAAI
COVID-19 in Pregnant Women With Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance

风湿病孕妇的新型冠状病毒肺炎: 来自新型冠状病毒肺炎全球风湿病学联盟的数据

2021-09-018
OA